Global Pharmaceutical Grade Marijuana Market By Type (Sativex , Cesamet , Marinol , Dexanabinol , Cannabinor , and Others), By Application (Research & Academic Laboratories , Pharmaceutical & Biotechnology Companies , and Hospitals), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2020-2029
- account_circleAbout Me
- 50735
- $3,495.00
- $5,100.00
- $7,200.00
Global Pharmaceutical Grade Marijuana Market is estimated to be valued US$ XX.X million in 2019. The report on Pharmaceutical Grade Marijuana Market provides qualitative as well as quantitative analysis in terms of market dynamics, competition scenarios, opportunity analysis, market growth, etc. for the forecast year up to 2029. The global pharmaceutical grade marijuana market is segmented on the basis of type, application, and geography.
Europe market was valued at US$ XX.X million in 2018 and is projected to reach US$ XX.X million in 2029, and register a CAGR of X.X% during the forecast period, according to a new Market.us (Prudour Research) study.
Pharmaceutical Grade Marijuana Market Scope:
By type, the market is segmented into Sativex, Cesamet, Marinol, Dexanabinol, Cannabinor, and Others. By application, the market is divided into Research & Academic Laboratories, Pharmaceutical & Biotechnology Companies, and Hospitals.
Based on geography, the market is analyzed across North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Major players profiled in the report include Merck, Pharmos, GW Pharmaceuticals, Valeant Pharmaceuticals International, Unimed Pharmaceuticals, Solvay Pharmaceuticals, Sanofi-Aventis, Medical Marijuana Inc, and Teva Pharmaceutical.
Key Market Segments
Type
- Sativex
- Cesamet
- Marinol
- Dexanabinol
- Cannabinor
- Others
Application
- Research & Academic Laboratories
- Pharmaceutical & Biotechnology Companies
- Hospitals
Key Market Players included in the report:
- Merck
- Pharmos
- GW Pharmaceuticals
- Valeant Pharmaceuticals International
- Unimed Pharmaceuticals
- Solvay Pharmaceuticals
- Sanofi-Aventis
- Medical Marijuana Inc
- Teva Pharmaceutical
Reasons to Get this Report:
In an insight outlook, this research report has dedicated to several quantities of analysis - industry research (global industry trends) and Pharmaceutical Grade Marijuana Market share analysis of high players, along with company profiles, and which collectively include about the fundamental opinions regarding the market landscape; emerging and high-growth sections of Pharmaceutical Grade Marijuana Market; high-growth regions; and market drivers, restraints, and also market chances.
The analysis covers Pharmaceutical Grade Marijuana Market and its advancements across different industry verticals as well as regions. It targets estimating the current market size and growth potential of the global Pharmaceutical Grade Marijuana Market across sections such as also application and representatives.
Additionally, the analysis also has a comprehensive review of the crucial players on the Pharmaceutical Grade Marijuana Market together side their company profiles, SWOT analysis, latest advancements, and business plans.
The analysis objectives of the report are:
- To equitably share in-depth info regarding the crucial elements impacting the increase of industry (growth capacity, chances, drivers, and industry-specific challenges and risks).
- To know the Pharmaceutical Grade Marijuana Market by pinpointing its many subsegments.
- To profile the important players and analyze their growth plans.
- To endeavor the amount and value of Pharmaceutical Grade Marijuana sub-markets, depending on key regions (various vital states).
- To analyze Pharmaceutical Grade Marijuana Market concerning growth trends, prospects, and also their participation in the entire sector.
- To examine and study the Pharmaceutical Grade Marijuana Market size (volume & value) from the company, essential regions/countries, products, and application, background information from 2013 to 2018, and also prediction to 2029.
- Primary worldwide Pharmaceutical Grade Marijuana Market manufacturing companies, to specify, clarify and analyze the product sales amount, value and market share, market rivalry landscape, SWOT analysis and development plans next coming years.
- To examine competitive progress such as expansions, arrangements, new product launches, and acquisitions on the market.
For the Pharmaceutical Grade Marijuana Market research study, the following years have been considered to estimate the market size:
Particular Scope Region - North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Historic Year 2015 to 2020 Estimated Year 2021 Forecast Year 2022 to 2031 - account_circleAbout Me
- 50735
- $3,495.00
- $5,100.00
- $7,200.00
- 1. Pharmaceutical Grade Marijuana Market Introduction
- 1.1. Definition
- 1.2. Taxonomy
- 1.3. Research Scope
- 2. Executive Summary
- 2.1. Key Findings by Major Segments
- 2.2. Top strategies by Major Players
- 3. Global Pharmaceutical Grade Marijuana Market Overview
- 3.1. Pharmaceutical Grade Marijuana Market Dynamics
- 3.1.1. Drivers
- 3.1.2. Opportunities
- 3.1.3. Restraints
- 3.1.4. Challenges
- 3.2. PESTLE Analysis
- 3.3. Opportunity Map Analysis
- 3.4. PORTER'S Five Forces Analysis
- 3.5. Market Competition Scenario Analysis
- 3.6. Product Life Cycle Analysis
- 3.7. Opportunity Orbits
- 3.8. Production Analysis by Region/Company
- 3.9. Industry chain Analysis
- 3.10. Marketing Strategy
- 3.1. Pharmaceutical Grade Marijuana Market Dynamics
- 4. Global Pharmaceutical Grade Marijuana Market Value & Volume ((US$ Mn & '000 Units)), Share (%), and Growth Rate (%) Comparison by Type, 2012-2028
- 4.1. Global Pharmaceutical Grade Marijuana Market Analysis by Type: Introduction
- 4.2. Market Size and Forecast by Region
- 4.3. Sativex
- 4.4. Cesamet
- 4.5. Marinol
- 4.6. Dexanabinol
- 4.7. Cannabinor
- 4.8. Others
- 5. Global Pharmaceutical Grade Marijuana Market Value & Volume ((US$ Mn & '000 Units)), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
- 5.1. Global Pharmaceutical Grade Marijuana Market Analysis by Application: Introduction
- 5.2. Market Size and Forecast by Region
- 5.3. Research & Academic Laboratories
- 5.4. Pharmaceutical & Biotechnology Companies
- 5.5. Hospitals
- 6. Global Pharmaceutical Grade Marijuana Market Value & Volume ((US$ Mn & '000 Units)), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
- 6.1. North America
- 6.1.1. North America Pharmaceutical Grade Marijuana Market: Regional Trend Analysis
- 6.1.1.1. US
- 6.1.1.2. Canada
- 6.1.1.3. Mexico
- 6.1.1. North America Pharmaceutical Grade Marijuana Market: Regional Trend Analysis
- 6.2.1. Europe
- 6.2.1. Europe Pharmaceutical Grade Marijuana Market: Regional Trend Analysis
- 6.2.1.1. Germany
- 6.2.1.2. France
- 6.2.1.3. UK
- 6.2.1.4. Russia
- 6.2.1.5. Italy
- 6.2.1.6. Spain
- 6.2.1.7. Rest of Europe
- 6.2.1. Europe Pharmaceutical Grade Marijuana Market: Regional Trend Analysis
- 6.3. Asia-Pacific
- 6.3.1. Asia-Pacific Pharmaceutical Grade Marijuana Market: Regional Trend Analysis
- 6.3.1.1. China
- 6.3.1.2. Japan
- 6.3.1.3. Korea
- 6.3.1.4. India
- 6.3.1.5. Rest of Asia-Pacific
- 6.3.1. Asia-Pacific Pharmaceutical Grade Marijuana Market: Regional Trend Analysis
- 6.4. Latin America
- 6.4.1. Latin America Pharmaceutical Grade Marijuana Market: Regional Trend Analysis
- 6.4.1.1. Brazil
- 6.4.1.2. Argentina
- 6.4.1.3. Rest of Latin America
- 6.4.1. Latin America Pharmaceutical Grade Marijuana Market: Regional Trend Analysis
- 6.5. Middle East and Africa
- 6.5.1. Middle East and Africa Pharmaceutical Grade Marijuana Market: Regional Trend Analysis
- 6.5.1.1. GCC
- 6.5.1.2. South Africa
- 6.5.1.3. Israel
- 6.5.1.4. Rest of MEA
- 6.5.1. Middle East and Africa Pharmaceutical Grade Marijuana Market: Regional Trend Analysis
- 6.1. North America
- 7. Global Pharmaceutical Grade Marijuana Market Competitive Landscape, Market Share Analysis, and Company Profiles
- 7.1. Market Share Analysis
- 7.2. Company Profiles
- 7.3. Merck
- 7.3.1. Company Overview
- 7.3.2. Financial Highlights
- 7.3.3. Product Portfolio
- 7.3.4. SWOT Analysis
- 7.3.5. Key Strategies and Developments
- 7.4. Pharmos
- 7.4.1. Company Overview
- 7.4.2. Financial Highlights
- 7.4.3. Product Portfolio
- 7.4.4. SWOT Analysis
- 7.4.5. Key Strategies and Developments
- 7.5. GW Pharmaceuticals
- 7.5.1. Company Overview
- 7.5.2. Financial Highlights
- 7.5.3. Product Portfolio
- 7.5.4. SWOT Analysis
- 7.5.5. Key Strategies and Developments
- 7.6. Valeant Pharmaceuticals International
- 7.6.1. Company Overview
- 7.6.2. Financial Highlights
- 7.6.3. Product Portfolio
- 7.6.4. SWOT Analysis
- 7.6.5. Key Strategies and Developments
- 7.7. Unimed Pharmaceuticals
- 7.7.1. Company Overview
- 7.7.2. Financial Highlights
- 7.7.3. Product Portfolio
- 7.7.4. SWOT Analysis
- 7.7.5. Key Strategies and Developments
- 7.8. Solvay Pharmaceuticals
- 7.8.1. Company Overview
- 7.8.2. Financial Highlights
- 7.8.3. Product Portfolio
- 7.8.4. SWOT Analysis
- 7.8.5. Key Strategies and Developments
- 7.9. Sanofi-Aventis
- 7.9.1. Company Overview
- 7.9.2. Financial Highlights
- 7.9.3. Product Portfolio
- 7.9.4. SWOT Analysis
- 7.9.5. Key Strategies and Developments
- 7.10. Medical Marijuana Inc
- 7.10.1. Company Overview
- 7.10.2. Financial Highlights
- 7.10.3. Product Portfolio
- 7.10.4. SWOT Analysis
- 7.10.5. Key Strategies and Developments
- 7.11. Teva Pharmaceutical
- 7.11.1. Company Overview
- 7.11.2. Financial Highlights
- 7.11.3. Product Portfolio
- 7.11.4. SWOT Analysis
- 7.11.5. Key Strategies and Developments
- 8. Assumptions and Acronyms
- 9. Research Methodology
- 10. Contact
- ondemand_videoVideos
- 50735
- $3,495.00
- $5,100.00
- $7,200.00
- Merck
- Pharmos
- GW Pharmaceuticals
- Valeant Pharmaceuticals International
- Unimed Pharmaceuticals
- Solvay Pharmaceuticals
- Sanofi-Aventis
- Medical Marijuana Inc
- Teva Pharmaceutical
- settingsSettings